Decreased plasma levels and dietary intake of minerals in women with migraine
Authors:
- Mariele Lino SilvaMSMariele Lino Silva
- Laís Bhering MartinsLMLaís Bhering Martins
- Luana Caroline dos SantosLSLuana Caroline dos Santos
- Gilberto Simeone HenriquesGHGilberto Simeone Henriques
- Antonio Lucio TeixeiraAntonio Lucio Teixeira
- Ana Maria dos Santos RodriguesARAna Maria dos Santos Rodrigues
- Adaliene Versiani Matos FerreiraAFAdaliene Versiani Matos Ferreira
- 3 June 2022
- journal article
- research article
- Published by Taylor & Francis in Nutritional Neuroscience
- Vol. 26 (7) , 629-636
Abstract
It has been suggested that an imbalance in mineral levels is involved in the pathophysiology of migraine. However, only a few studies have investigated the circulating levels of mineral in patients with migraine during the pain-free period (i.e. interictal). This study aimed to investigate whether the interictal plasma levels of minerals of women with migraine differ from those of women without migraine (controls). This is a cross-sectional study involving 67 women, of which 38 were diagnosed with migraine and 29 were controls. The groups were similar in age and body mass index. Plasma levels of magnesium (Mg), copper (Cu), calcium (Ca), zinc (Zn), iron (Fe), and selenium (Se) were measured. Dietary intake was assessed using a 24-hour food recall, and migraine impact was evaluated using the Headache Impact Test, version 6 (HIT-6). The association between migraine disability, and plasma levels and dietary intake of minerals was assessed through correlation and logistic regression analyses. Women with migraine had significantly lower plasma levels of Mg, Ca, Cu, and Zn than controls. In parallel, dietary intake of Mg, Cu, and Fe was significantly lower in patients with migraine. Migraine impact was not associated with plasma levels or dietary intake of minerals. The results suggest that patients with migraine have lower plasma levels of minerals, and dietary intervention to ensure adequate mineral intake should be considered as a therapeutic strategy for migraine.Keywords
Funding Information
- Brazilian government funding agencies: Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais a Pesquisa do Estado de Minas Gerais
This publication has 38 references indexed in Scilit:
- Preventive treatment in migraine and the new US guidelinesNeuropsychiatric Disease and Treatment, 2013
- Duration and Severity of Symptoms and Levels of Plasma Interleukin-1 Receptor Antagonist, Soluble Tumor Necrosis Factor Receptor, and Adhesion Molecules in Patients with Common Cold Treated with Zinc AcetateThe Journal of Infectious Diseases, 2008
- Deficiências de mineraisEstudos Avançados, 2007
- NMDA receptor pathways as drug targetsNature Neuroscience, 2002
- Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjectsCurrent Therapeutic Research, 1998
- Migrainous Disorder and its Relation to Migraine Without Aura and Migraine with Aura. A Genetic Epidemiological StudyCephalalgia, 1996
- Prophylaxis of Migraine with Oral Magnesium: Results From A Prospective, Multi-Center, Placebo-Controlled and Double-Blind Randomized StudyCephalalgia, 1996
- Intravenous Magnesium Sulfate Relieves Cluster Headaches in Patients With Low Serum Ionized Magnesium LevelsHeadache: The Journal of Head and Face Pain, 1995
- Alleviation of Migraines with Therapeutic Vitamin D and CalciumHeadache: The Journal of Head and Face Pain, 1994
- Migraine With Aura and Migraine Without Aura: An Epidemiological StudyCephalalgia, 1992